Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.30 USD
Change Today 0.00 / 0.00%
Volume 0.0
CRXM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William Sessa Ph.D.

Member of Scientific Advisory Board, Taxus Cardium Pharmaceuticals Group Inc.
AgeTotal Calculated CompensationThis person is connected to 55 board members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background*

Dr. William Sessa, Ph.D. serves as Vice Chairman and Professor of the Department of Pharmacology at the Yale School of Medicine. Dr. Sessa has achieved national and international recognition for the development and application of basic cellular and molecular biological techniques to physiologically important questions in the cardiovascular system. Dr. Sessa serves as Director of the Vascular Biology and Transplantation Program at Yale University School of Medicine. He ...

Read Full Background

Corporate Headquarters*

11750 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-436-1000
Fax: 858-436-1001

Board Members Memberships*

Director

Education*

MS
University Of Rhode Island
PhD
New York Medical College
Bachelor's Degree
University of the Sciences In Philadelphia

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRXM:US $0.30 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Parker H. Petit Chairman and Chief Executive Officer
MiMedx Group, Inc.
$914.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAXUS CARDIUM PHARMACEUTICAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.